<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1.0"><title>Heart Health — SugarWise</title><link rel="stylesheet" href="styles.css"></head><body>
<nav class="navbar"><div class="navbar-inner"><a class="brand" href="index.html">SugarWise</a><a class="home-link" href="index.html">All Topics</a></div></nav>
<div class="container">
<div class="page-header"><h1>Heart Health &amp; Cardiovascular Disease</h1><p>Cardiovascular disease is the leading cause of death in people with diabetes. Understanding risk factors and protective strategies is essential.</p></div>

<div class="illus">
<svg width="220" height="130" viewBox="0 0 220 130" fill="none" xmlns="http://www.w3.org/2000/svg">
<!-- heart shape -->
<g transform="translate(60,10)">
<path d="M50 95 C50 95,0 55,0 30 C0 10,15 0,30 0 C40 0,48 8,50 15 C52 8,60 0,70 0 C85 0,100 10,100 30 C100 55,50 95,50 95Z" fill="#e53e3e" opacity="0.85">
<animate attributeName="opacity" values="0.85;0.65;0.85" dur="1s" repeatCount="indefinite"/>
<animateTransform attributeName="transform" type="scale" values="1;1.05;1" dur="1s" repeatCount="indefinite" additive="sum" origin="50 50"/>
</path>
</g>
<!-- pulse line -->
<polyline points="0,75 40,75 55,75 65,45 75,100 85,55 95,75 130,75 145,75 155,45 165,100 175,55 185,75 220,75" stroke="#e53e3e" stroke-width="2.5" fill="none" stroke-linecap="round" stroke-linejoin="round">
<animate attributeName="stroke-dashoffset" from="500" to="0" dur="2s" repeatCount="indefinite"/>
<animate attributeName="stroke-dasharray" values="0 500;250 250;500 0" dur="2s" repeatCount="indefinite"/>
</polyline>
</svg>
</div>

<div class="section">
<h2><span class="icon-sm">&#128148;</span> The Diabetes-Heart Connection</h2>
<p>Cardiovascular disease (CVD) accounts for approximately 50-80% of deaths in people with diabetes. Adults with Type 2 diabetes have a 2-4 times higher risk of heart attack and stroke compared to people without diabetes. This excess risk persists even after adjusting for traditional risk factors like smoking and cholesterol.</p>
<p>Diabetes accelerates atherosclerosis through multiple mechanisms: chronic hyperglycemia, insulin resistance, dyslipidemia (high triglycerides, low HDL, small dense LDL), hypertension, chronic inflammation, oxidative stress, and endothelial dysfunction.</p>
<div class="warning">Many people with diabetes experience "silent" heart attacks with minimal or atypical symptoms (fatigue, shortness of breath, nausea) rather than classic chest pain. Maintain a high index of suspicion and report any unusual symptoms.</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#9888;</span> Key Risk Factors</h2>
<div class="table-wrap">
<table>
<thead>
<tr><th>Risk Factor</th><th>Impact in Diabetes</th></tr>
</thead>
<tbody>
<tr><td>Hyperglycemia</td><td>Promotes endothelial damage, AGE formation, and oxidative stress</td></tr>
<tr><td>Hypertension</td><td>Present in 60-80% of people with Type 2 diabetes; doubles CVD risk</td></tr>
<tr><td>Dyslipidemia</td><td>Diabetic dyslipidemia (high TG, low HDL, small dense LDL) is highly atherogenic</td></tr>
<tr><td>Obesity / visceral fat</td><td>Drives insulin resistance, inflammation, and multiple metabolic abnormalities</td></tr>
<tr><td>Smoking</td><td>Synergistic risk — dramatically accelerates vascular damage on top of diabetes</td></tr>
<tr><td>Physical inactivity</td><td>Worsens insulin resistance, lipids, blood pressure, and weight</td></tr>
<tr><td>Chronic kidney disease</td><td>Strongly associated with CVD; shared risk factors amplify each other</td></tr>
<tr><td>Family history of premature CVD</td><td>Genetic predisposition compounds diabetes-related risk</td></tr>
</tbody>
</table>
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#128137;</span> Blood Pressure Management</h2>
<p>Hypertension is extremely common in diabetes and is a major driver of both macrovascular and microvascular complications.</p>
<ul>
<li><strong>Target:</strong> &lt;130/80 mmHg for most adults with diabetes (ADA/AHA recommendation).</li>
<li><strong>First-line medications:</strong> ACE inhibitors (e.g., ramipril, enalapril) or ARBs (e.g., losartan, telmisartan) — preferred because they also protect the kidneys.</li>
<li>Additional agents as needed: calcium channel blockers (amlodipine), thiazide diuretics.</li>
<li>Home blood pressure monitoring is recommended for accurate assessment.</li>
<li>Lifestyle measures: sodium restriction (&lt;2,300 mg/day, ideally &lt;1,500 mg), DASH diet, regular exercise, weight loss, moderation of alcohol.</li>
</ul>
<div class="note">Do not combine ACE inhibitors and ARBs together — this increases the risk of hyperkalemia and renal impairment without additional benefit.</div>
<div class="gauge-row">
<div class="gauge"><div class="gauge-circle green" style="--pct:72%"><span>&lt;130</span></div><div class="gauge-label">Systolic BP (mmHg)</div></div>
<div class="gauge"><div class="gauge-circle green" style="--pct:60%"><span>&lt;80</span></div><div class="gauge-label">Diastolic BP (mmHg)</div></div>
<div class="gauge"><div class="gauge-circle orange" style="--pct:55%"><span>&lt;100</span></div><div class="gauge-label">LDL (mg/dL)</div></div>
<div class="gauge"><div class="gauge-circle red" style="--pct:40%"><span>&lt;70</span></div><div class="gauge-label">LDL High-Risk</div></div>
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#128201;</span> Lipid Management</h2>
<h3>Targets</h3>
<ul>
<li><strong>LDL cholesterol:</strong> &lt;100 mg/dL for most adults with diabetes; &lt;70 mg/dL (or 50% reduction) for those with established CVD or high risk.</li>
<li><strong>Triglycerides:</strong> &lt;150 mg/dL.</li>
<li><strong>HDL:</strong> &gt;40 mg/dL (or &gt;50 mg/dL depending on individual risk factors).</li>
<li><strong>Non-HDL cholesterol:</strong> &lt;130 mg/dL (or &lt;100 mg/dL for very high risk).</li>
</ul>
<h3>Statin Therapy</h3>
<ul>
<li><strong>Moderate-intensity statin</strong> (e.g., atorvastatin 10-20 mg, rosuvastatin 5-10 mg): recommended for all adults with diabetes aged 40-75 without established CVD.</li>
<li><strong>High-intensity statin</strong> (e.g., atorvastatin 40-80 mg, rosuvastatin 20-40 mg): recommended for those with established CVD or multiple risk factors.</li>
<li>For ages 20-39, consider a statin if additional risk factors are present.</li>
<li>If LDL remains above target on maximum tolerated statin, add ezetimibe or a PCSK9 inhibitor.</li>
</ul>
<div class="tip">Statins are one of the most evidence-backed interventions in diabetes. Side effects (muscle aches) are uncommon. Do not stop your statin without discussing with your doctor — the cardiovascular benefits far outweigh the risks for most people.</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#128138;</span> Antiplatelet Therapy</h2>
<ul>
<li><strong>Secondary prevention:</strong> Low-dose aspirin (75-162 mg/day) is recommended for all people with diabetes and established CVD (prior heart attack, stroke, or PAD).</li>
<li><strong>Primary prevention:</strong> Consider aspirin for those with diabetes at higher CVD risk (10-year ASCVD risk &gt;10%) after discussing bleeding risk. Not routinely recommended for low-risk individuals.</li>
<li>Clopidogrel is an alternative for those who are aspirin-intolerant.</li>
<li>Dual antiplatelet therapy (aspirin + clopidogrel) after acute coronary syndrome or stent placement, typically for 12 months.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#128154;</span> ACE Inhibitors and ARBs</h2>
<p>Beyond blood pressure control, these agents provide cardiovascular and renal protection:</p>
<ul>
<li>Reduce left ventricular hypertrophy and heart failure progression.</li>
<li>Protect against diabetic nephropathy by reducing intraglomerular pressure.</li>
<li>Recommended as first-line antihypertensive in diabetes, especially with albuminuria.</li>
<li>Monitor serum creatinine and potassium within 1-2 weeks of initiation or dose change.</li>
<li>Contraindicated in pregnancy.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#128522;</span> Cardiovascular Benefits of Newer Diabetes Medications</h2>
<h3>SGLT2 Inhibitors (empagliflozin, canagliflozin, dapagliflozin)</h3>
<ul>
<li>Demonstrated reduction in major adverse cardiovascular events (MACE) in landmark trials (EMPA-REG OUTCOME, CANVAS, DECLARE-TIMI 58).</li>
<li>Significant reduction in heart failure hospitalization (30-35% relative risk reduction).</li>
<li>Renal protective effects (slow progression of CKD).</li>
<li>Benefits appear to be partly independent of glucose lowering.</li>
<li>Now recommended by guidelines for people with diabetes and established CVD, heart failure, or CKD regardless of HbA1c.</li>
</ul>
<h3>GLP-1 Receptor Agonists (liraglutide, semaglutide, dulaglutide)</h3>
<ul>
<li>Reduce MACE (cardiovascular death, non-fatal MI, non-fatal stroke) in trials (LEADER, SUSTAIN-6, REWIND).</li>
<li>Promote weight loss (3-7 kg on average), which provides additional metabolic benefits.</li>
<li>Reduce blood pressure and improve lipid profile.</li>
<li>Recommended for people with diabetes and established atherosclerotic CVD or high CVD risk.</li>
</ul>
<div class="note">Current ADA/EASD guidelines recommend adding an SGLT2 inhibitor or GLP-1 RA with proven cardiovascular benefit for people with Type 2 diabetes who have established CVD, heart failure, or CKD — independent of HbA1c level or metformin use.</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#127939;</span> Lifestyle Modifications for Heart Health</h2>
<ul>
<li><strong>Physical activity:</strong> At least 150 minutes/week of moderate-intensity aerobic exercise (brisk walking, cycling, swimming) plus 2-3 sessions of resistance training.</li>
<li><strong>Diet:</strong> Mediterranean or DASH dietary pattern — rich in vegetables, fruits, whole grains, legumes, nuts, fish, and olive oil; limit saturated fat, trans fat, sodium, and added sugars.</li>
<li><strong>Weight management:</strong> Even 5-10% weight loss significantly improves cardiovascular risk factors.</li>
<li><strong>Smoking cessation:</strong> The single most impactful lifestyle change for reducing CVD risk. Seek support through counseling and pharmacotherapy (varenicline, NRT) if needed.</li>
<li><strong>Alcohol:</strong> If consumed, limit to 1&ndash;2 drinks/day depending on body size. Avoid binge drinking.</li>
<li><strong>Stress management:</strong> Chronic stress elevates cortisol and blood glucose. Consider mindfulness, therapy, and regular sleep.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#128148;</span> Heart Failure in Diabetes</h2>
<p>People with diabetes are at 2-5 times higher risk of heart failure, even without coronary artery disease. This includes heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).</p>
<ul>
<li>Symptoms: shortness of breath, fatigue, swelling in legs/ankles, rapid weight gain.</li>
<li>SGLT2 inhibitors are now a cornerstone of heart failure treatment in people with diabetes (and even without diabetes).</li>
<li>Avoid thiazolidinediones (pioglitazone, rosiglitazone) in patients with heart failure — they cause fluid retention.</li>
<li>Metformin is safe in stable heart failure but should be held during acute decompensation.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#128680;</span> When to Seek Urgent Care</h2>
<div class="warning">Call emergency services immediately if you experience:
<ul>
<li>Chest pain, pressure, or tightness lasting more than a few minutes</li>
<li>Pain radiating to the arm, jaw, neck, or back</li>
<li>Sudden shortness of breath</li>
<li>Sudden weakness or numbness on one side of the body</li>
<li>Sudden difficulty speaking or understanding speech</li>
<li>Sudden severe headache with no known cause</li>
<li>Loss of consciousness</li>
</ul>
</div>
</div>

<div class="page-nav">
<a class="prev" href="complications-overview.html">Complications Overview</a>
<a class="next" href="kidney-health.html">Kidney Health</a>
</div>
</div>
<div class="disclaimer">This content is for educational purposes only and does not replace professional medical advice. Always consult a qualified endocrinologist / diabetologist before making any changes to your diabetes management plan.</div>
<div class="footer">SugarWise &bull; Comprehensive Diabetes Management Companion &bull; Last updated: January 2026</div>
<button class="scroll-top" id="scrollTop" title="Back to top">&uarr;</button>
<script>
var sb=document.getElementById('scrollTop');window.addEventListener('scroll',function(){sb.classList.toggle('visible',window.scrollY>400)});sb.addEventListener('click',function(){window.scrollTo({top:0,behavior:'smooth'})});
</script>
</body></html>